Trial Profile
Genous stent in high-risk patients with known contraindications for dual antiplatelet therapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Jan 2011
Price :
$35
*
At a glance
- Drugs Anti-CD34 monoclonal antibody (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Sponsors OrbusNeich
- 11 Jan 2011 New trial record
- 10 Jan 2011 Results have been published online in EuroIntervention, according to an Orbus Neich media release.